David A. Siegel Verrica Pharmaceuticals Inc. Transaction History

Two Sigma Advisers, LP

  • $43.8 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$5.32 - $6.79 $28,728 - $36,666
5,400 Added 25.84%
26,300 $151,000
Q1 2023

May 15, 2023
SELL
$2.88 - $8.51 $34,560 - $102,120
-12,000 Reduced 36.47%
20,900 $135,000
Q4 2022

Feb 14, 2023
BUY
$2.09 - $3.39 $42,427 - $68,817
20,300 Added 161.11%
32,900 $90,000
Q3 2022

Nov 14, 2022
BUY
$2.17 - $4.3 $27,342 - $54,180
12,600 New
12,600 $37,000

Others Institutions Holding VRCA

# of Institutions
71
Shares Held
17.4M
Call Options Held
6.1K
Put Options Held
6.3K
View Full List

About Verrica Pharmaceuticals Inc.

VRCA Quotes by TradingView
  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email